Last edition
News about "GlaxoSmithKline "
Alembic Secures US FDA Approval for Migraine Treatment Autoinjector
The approved product is therapeutically equivalent to the reference-listed drug, Imitrex STATdose System, priorly marketed by GlaxoSmithKline.
GlaxoSmithKline. | 11/11/2025 | By Darshana | 105
Global Topical Antibiotics Market Projected to Surpass USD 11 Billion by 2032
The global topical antibiotics market, valued at USD 6.42 billion in 2024, is expected to reach nearly USD 11.20 billion by 2032.
GlaxoSmithKline | 14/07/2025 | By Dineshwori | 184
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy